Synchronous colorectal cancer and multiple myeloma with chest wall involvement: Is this a coincidence?

Curr Probl Cancer. 2017 Nov-Dec;41(6):413-418. doi: 10.1016/j.currproblcancer.2017.09.002. Epub 2017 Sep 25.

Abstract

Multiple primary malignant neoplasms (MPMNs) are rare malignant neoplasms that simultaneously or successively occur in the same patient as 2 or more primary malignancies. Currently, an increasing number of cases are being reported. In general, MPMNs more commonly occur as 2 solid tumors or 2 hematological malignancies. Cases of MPMN that involve a solid tumor and a hematological malignancy are rare. Here, we report a case of synchronous colorectal cancer (CRC) and multiple myeloma (MM) with chest wall involvement. After reviewing the literature, we believe that there may be a distinct syndrome involving CRC and MM. The patient in our case study suffered refractory anemia following surgery and 2 cycles of chemotherapy. Initially, the anemia was considered to be a common manifestation of CRC in this patient. Interestingly, although he received a blood transfusion, his hemoglobin levels remained low. He later developed hematuria, proteinuria, multiple osteoporosis in the costal bones, and thrombocytopenia. These new symptoms drew our attention, and we considered a diagnosis of synchronous primary CRC and MM, with the anemia as a symptom of MM. Based on the results of a bone marrow aspirate, MM was confirmed. Therefore, when CRC is associated with refractory anemia, we should not only assume that anemia is a classical symptom of CRC, a result of chronic blood loss, nutritional deficiencies, or myelosuppression due to chemotherapy, but we should also consider that it may reflect the possibility of a coexisting hematologic malignancy. As the treatment of these 2 malignancies is different, early diagnosis and treatment based on definitive diagnosis as early as possible will be beneficial to overall prognosis.

Keywords: Anemia; Colorectal cancer; Multiple myeloma; Multiple primary malignant neoplasms.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adenocarcinoma / blood
  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / pathology
  • Adenocarcinoma / therapy*
  • Anemia, Refractory / blood
  • Anemia, Refractory / diagnosis
  • Anemia, Refractory / etiology
  • Anemia, Refractory / therapy*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Biopsy
  • Chemotherapy, Adjuvant / adverse effects
  • Colectomy
  • Colonoscopy
  • Colorectal Neoplasms / blood
  • Colorectal Neoplasms / diagnosis
  • Colorectal Neoplasms / pathology
  • Colorectal Neoplasms / therapy*
  • Early Detection of Cancer
  • Fluorouracil / adverse effects
  • Humans
  • Leucovorin / adverse effects
  • Male
  • Middle Aged
  • Multiple Myeloma / blood
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / pathology
  • Multiple Myeloma / therapy*
  • Neoplasms, Multiple Primary / blood
  • Neoplasms, Multiple Primary / diagnosis
  • Neoplasms, Multiple Primary / pathology
  • Neoplasms, Multiple Primary / therapy*
  • Organoplatinum Compounds / adverse effects
  • Prognosis
  • Syndrome
  • Thoracic Wall / pathology
  • Tomography, X-Ray Computed

Substances

  • Organoplatinum Compounds
  • Leucovorin
  • Fluorouracil

Supplementary concepts

  • Folfox protocol